1. Adamson PC, Balis FM, Miser J, Arndt C, Wells RJ, Gillespie A, Aronson L, Penta JS, Clendeninn NJ, Poplack DG (1992) Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res 52:521–524
2. Balis FM, Patel R, Luks E, Doherty KM, Holcenberg JS, Tan C, Reaman GH, Belasco J, Ettinger LJ, Zimm S et al (1987) Pediatric phase I trial and pharmacokinetic study of trimetrexate. Cancer Res 47:4973–4976
3. Balis FM, Savitch JL, Bleyer WA (1983) Pharmacokinetics of oral methotrexate in children. Cancer Res 43:2342–2345
4. Burchenal JH, Karnofsky DA, Kingsley-Pillers EM, Southam CM, Myers WP, Escher GC, Craver LF, Dargeon HW, Rhoads CP (1951) The effects of the folic acid antagonists and 2, 6-diaminopurine on neoplastic disease, with special reference to acute leukemia. Cancer 4:549–569
5. Cao S, McGuire JJ, Rustum YM (1999) Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine. Clin Cancer Res 5:1925–1934